Medical Value Travel (MVT) in India

Medical Value Travel (MVT) refers to patients traveling across borders to access high-quality healthcare at affordable costs, often combined with wellness and tourism. It goes beyond traditional medical tourism by emphasizing value through clinical outcomes, accreditation, and patient experience.

India plays a pivotal role in global MVT due to its cost advantage—treatments are 65–90% cheaper than in Western countries—alongside world-class hospitals, skilled doctors, and advanced technologies like robotic surgery.

The government’s “Heal in India” initiative supports this sector with streamlined e-medical visas, digital portals, and integration of AYUSH for holistic care. India’s MVT market, valued at $6–8 billion in 2024, is projected to reach $14.3 billion by 2029, attracting millions of international patients annually for procedures such as cardiac surgery, organ transplants, and fertility treatments. Combining affordability, quality, and wellness, India is positioning itself as a global hub for medical value travel.

Below menioned is an overview of Medical Value Travel (MVT)—the evolved concept of medical tourism focused on delivering comprehensive value:

What is Medical Value Travel (MVT)?

MVT refers to cross-border travel for healthcare, emphasizing quality, affordable care combined with positive patient experiences—specifically value, not just low cost.
It blends accessible pricing, shorter wait times, internationally accredited facilities, English-speaking staff, and appealing recovery environments.

Global Market Size & Growth Forecast

The global medical tourism market reached $82.7 billion in 2024, and is projected to grow to $92.6 billion in 2025 (~12% CAGR).
Growth is forecasted to continue, with estimates ranging:
- $186.99 billion by 2029 (CAGR ~19%),
- $890 billion by 2035 (~10% CAGR).

Key Driving Factors

Dramatic Cost Savings
- Patients can save 50–90% on procedures compared to U.S./Western countries.
- Example: Heart bypass surgery—$9k–$15k in India vs. $70k–$130k in U.S..
Reduced Waiting Times
- Patients enjoy much faster scheduling, avoiding months or years of wait lists, especially in public systems.
Access to Advanced & Specialized Treatments
- Includes high-end procedures like robotic surgery, stem-cell therapy, transplants, fertility, and cosmetic treatments.
Quality and Accreditation
- Many hospitals have JCI or other internationally recognized accreditations.
- Facilities offer personalized care, language support, post-op services.
Holistic Recovery Experience
- Destinations combine treatment with wellness and tourism elements, creating a therapeutic environment.

Global Statistics Snapshot

Around 21 million medical travelers annually, with ~20% year-over-year market growth.
Market forecast: $97 billion in 2022, growing to $273.7 billion by 2027 (~12.8% CAGR).
Regional estimates: India procedures cost 65–90% less than in the U.S.

Top Medical Value Travel Destinations

According to analytics sources (e.g., DocScore, MTI):

Rank	Country	Highlights
1	UAE	Visa-friendly, high quality, fast-growing demand
2	South Korea	Advanced tech, top in oncology & cosmetic surgery
3–5	Brazil, Mexico, Thailand	Value-driven, JCI hospitals, varied procedures
6–10	Malaysia, Turkey, Costa Rica, Saudi Arabia, India	Strong accessibility & quality

Other notable names: Colombia, Czech Republic, among emerging hubs.

MVT vs. Value-Based Care

MVT focuses on transactional value: cost, convenience, and experience, typically fee-for-service.
Value-Based Care (VBC) in Western healthcare ties payment to patient outcomes, with accountability and longer-term care models.

Key Trends Shaping MVT in 2025

Telemedicine & Virtual Consults: Pre- and post-treatment care via telehealth for better coordination.
Wellness/Preventive Integration: Increasing demand for holistic health and lifestyle-focused packages.
Advanced Tech Adoption: Use of AI diagnostics, robotic surgery, IoT for personalized experiences.
Niche Markets: Growth in fertility treatments, regenerative medicine, high-acuity procedures.
Ethical & Quality Standards: Focus on accreditation, transparency, and regulatory compliance.

Spotlight: India’s MVT Proposition

MVT market ~$6–8 billion (2024), serving ~7.3 million patients; forecasted to reach $14.3 billion by 2029.
India offers world-class care at 65–90% lower cost, with 60+ JCI and 1,400+ NABH accredited hospitals.
Government support:
- ‘Heal in India’ initiative with e‑medical visas for 167 countries, a one-stop digital portal, and easing legal frameworks,
- Integration of AYUSH (Ayurveda, Yoga) for holistic offerings.
Strategic push into Tier 2/3 cities, regulated accreditation, national MVT council groundwork.
Shift from branding purely on affordability to clinical outcomes and specialization, building global credibility.

Conclusion

Medical Value Travel is a robust, rapidly expanding segment within healthcare, anchored in delivering value: affordability, quality, convenience, and holistic care.
While offering significant cost savings and access to advanced procedures, patients must prioritize accreditation, outcome transparency, and post-treatment care.
Emerging destinations—especially India—are transforming MVT with technology, personalization, and a broad ecosystem of wellness options, increasing both appeal and patient trust.

References :

Need Medical Value Travel In India and to connect with Indian Hospitals ??

← Back

Medical Value Travel (MVT)